Western Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Western Wealth Management's BMY Position: Q3 2026 in Review
Western Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 3.1% in Q3 2026, buying an estimated $42.4K and bringing the position to 22,469 shares worth $1.4M. The position accounts for 0.05% of the portfolio, ranked #375.
Western Wealth Management first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.17M in Q3 2022. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Western Wealth Management held 22,469 shares of Bristol-Myers Squibb worth $1.4M as of Q3 2026.
- Western Wealth Management bought 671 Bristol-Myers Squibb shares in Q3 2026, an estimated $42.4K.
- Bristol-Myers Squibb made up 0.05% of Western Wealth Management's portfolio in Q3 2026, its #375 holding.
- Western Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
- Western Wealth Management's Bristol-Myers Squibb position peaked at $3.17M in Q3 2022.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Western Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.